DrugPatentWatch Database Preview
Patent: 9,234,211
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Patent: 9,234,211
Title: | Hybrid promoter and recombinant vector comprising the same |
Abstract: | The present invention relates to a hybrid promoter, in which a whole or a part of a CMV enhancer, a whole or a part of a .beta.-actin promoter, a whole or a part of a CMV promoter, and a whole or a part of a .beta.-actin intron are operably linked to each other, a recombinant vector comprising the same, a transformant transformed with the recombinant vector, a pharmaceutical composition comprising the recombinant vector or the transformant, and a method for preparing a target protein using the recombinant vector or the transformant. The hybrid promoter of the present invention is able to induce high expression of a target protein in a eukaryotic cell. Therefore, the hybrid promoter of the present invention can be effectively used for the development of an antibody or the production of a DNA vaccine. |
Inventor(s): | Kim; Yeon Chul (Daejeon, KR), Jung; Saem (Daejeon, KR), Jung; Jun (Daejeon, KR) |
Assignee: | LG Life Sciences Ltd. (Seoul, KR) |
Application Number: | 13/990,546 |
Patent Claims: | see list of patent claims |
Details for Patent 9,234,211
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 003 | 1986-06-04 | Start Trial | LG Life Sciences Ltd. (Seoul, KR) | 2030-11-30 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 002 | 1986-06-04 | Start Trial | LG Life Sciences Ltd. (Seoul, KR) | 2030-11-30 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | LG Life Sciences Ltd. (Seoul, KR) | 2030-11-30 | RX | search | |
Smith And Nephew | SANTYL | collagenase | OINTMENT;TOPICAL | 101995 | 001 | 1965-06-04 | Start Trial | LG Life Sciences Ltd. (Seoul, KR) | 2030-11-30 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 9,234,211
Country | Patent Number | Publication Date |
---|---|---|
World Intellectual Property Organization (WIPO) | 2012074277 | Aug 09, 2012 |
World Intellectual Property Organization (WIPO) | 2012074277 | Jun 07, 2012 |
United States of America | 2013324593 | Dec 05, 2013 |
South Korea | 101038126 | May 31, 2011 |
Japan | 2014502159 | Jan 30, 2014 |
>Country | >Patent Number | >Publication Date |